Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedJul 17, 2024
DataAggregated Company Financials
Companies20
  • 7D0.9%
  • 3M6.7%
  • 1Y16.2%
  • YTD9.2%

Over the last 7 days, the Pharma industry has remained flat. The past year has been better, since the industry has gained 16% in that time. As for the next few years, earnings are expected to grow by 15% per annum.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 18 Jul 2024UK£256.4bUK£70.7bUK£9.4b35.1x27.2x3.6x
Sat, 15 Jun 2024UK£267.2bUK£71.6bUK£9.6b31.5x27.9x3.7x
Mon, 13 May 2024UK£273.5bUK£72.1bUK£9.6b37.4x28.4x3.8x
Wed, 10 Apr 2024UK£241.5bUK£70.7bUK£9.7b32.6x24.9x3.4x
Fri, 08 Mar 2024UK£237.3bUK£70.2bUK£9.7b30.9x24.5x3.4x
Sun, 04 Feb 2024UK£237.0bUK£69.8bUK£9.5b35.2x24.8x3.4x
Tue, 02 Jan 2024UK£235.0bUK£68.9bUK£10.7b35.5x22x3.4x
Thu, 30 Nov 2023UK£223.8bUK£69.0bUK£10.7b33.5x21x3.2x
Sat, 28 Oct 2023UK£229.1bUK£70.8bUK£10.4b54x22.1x3.2x
Mon, 25 Sep 2023UK£247.8bUK£70.5bUK£10.4b56.6x23.9x3.5x
Wed, 23 Aug 2023UK£235.3bUK£68.9bUK£10.2b53.5x23.2x3.4x
Fri, 21 Jul 2023UK£236.0bUK£67.4bUK£7.8b52x30.1x3.5x
Sun, 18 Jun 2023UK£251.8bUK£67.5bUK£7.9b55.5x32x3.7x
Tue, 16 May 2023UK£259.0bUK£68.3bUK£8.0b58.9x32.5x3.8x
Thu, 13 Apr 2023UK£256.4bUK£69.1bUK£6.9b55x37.4x3.7x
Sat, 11 Mar 2023UK£234.3bUK£70.5bUK£7.0b45x33.7x3.3x
Mon, 06 Feb 2023UK£236.0bUK£71.1bUK£6.3b38.1x37.2x3.3x
Wed, 04 Jan 2023UK£250.2bUK£80.5bUK£6.4b37.7x39.4x3.1x
Fri, 02 Dec 2022UK£242.6bUK£79.5bUK£6.3b37.1x38.5x3.1x
Sun, 30 Oct 2022UK£224.6bUK£79.6bUK£3.7b21.6x60.8x2.8x
Tue, 27 Sep 2022UK£217.8bUK£82.5bUK£3.6b13.4x59.9x2.6x
Thu, 25 Aug 2022UK£244.8bUK£78.8bUK£3.7b14.5x65.5x3.1x
Sat, 23 Jul 2022UK£251.2bUK£75.4bUK£4.6b14.6x54.9x3.3x
Mon, 20 Jun 2022UK£250.9bUK£74.6bUK£4.6b15.7x55x3.4x
Wed, 18 May 2022UK£265.7bUK£73.8bUK£4.6b16.8x58.1x3.6x
Fri, 15 Apr 2022UK£268.3bUK£66.7bUK£4.8b20.5x55.8x4x
Sun, 13 Mar 2022UK£237.1bUK£66.8bUK£4.7b24.1x50x3.5x
Tue, 08 Feb 2022UK£227.7bUK£61.3bUK£5.6b31.7x40.4x3.7x
Thu, 06 Jan 2022UK£230.6bUK£61.2bUK£5.6b32.4x41x3.8x
Sat, 04 Dec 2021UK£222.4bUK£61.9bUK£5.7b30.7x39.3x3.6x
Mon, 01 Nov 2021UK£236.6bUK£58.8bUK£7.4b26.4x31.8x4x
Wed, 29 Sep 2021UK£223.0bUK£58.6bUK£7.6b28.8x29.5x3.8x
Fri, 27 Aug 2021UK£227.8bUK£58.1bUK£7.5b29.3x30.4x3.9x
Price to Earnings Ratio

29.7x


Total Market Cap: UK£223.0bTotal Earnings: UK£7.5bTotal Revenue: UK£58.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 38.6x202220232024
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 27.2x which is lower than its 3-year average PE of 38.6x.
  • The industry is trading close to its 3-year average PS ratio of 3.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 8.0% per year over the last three years.
  • Revenues for these companies have grown 6.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market0.56%
Healthcare0.91%
Pharma0.92%
Pharma0.92%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£121.000.2%
+UK£341.1m		15.2%PE38.6x
HCM HUTCHMED (China)UK£2.8913.3%
+UK£290.3m		46.2%PE31.9x
HIK Hikma PharmaceuticalsUK£18.501.8%
+UK£73.2m		-5.2%PE28.2x
REDX Redx PharmaUK£0.1562.2%
+UK£22.4m		-53.8%PS13.9x
DPH Dechra PharmaceuticalsUK£38.660.2%
+UK£6.8m		32.4%PS5.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ANA

UK£0.005

Ananda Developments

7D

-4.8%

1Y

-2.0%

AZN

UK£121.00

AstraZeneca

7D

0.2%

1Y

15.2%

EAH

UK£1.24

ECO Animal Health Group

7D

-2.4%

1Y

10.2%

GSK

UK£15.01

GSK

7D

-0.3%

1Y

10.3%

HCM

UK£2.89

HUTCHMED (China)

7D

13.3%

1Y

46.2%

SAR

UK£0.36

Sareum Holdings

7D

9.8%

1Y

-62.6%

INDV

UK£7.83

Indivior

7D

0.4%

1Y

-57.7%

INC

UK£0.32

Incanthera

7D

18.5%

1Y

403.9%

REDX

UK£0.15

Redx Pharma

7D

62.2%

1Y

-53.8%

IMM

UK£0.021

ImmuPharma

7D

-5.7%

1Y

-16.1%

CEL

UK£0.61

Celadon Pharmaceuticals

7D

-13.2%

1Y

-59.9%

FUM

UK£0.36

Futura Medical

7D

-3.4%

1Y

-31.8%

POLB

UK£0.13

Poolbeg Pharma

7D

-3.3%

1Y

77.0%

OCTP

UK£0.0011

Oxford Cannabinoid Technologies Holdings

7D

-32.4%

1Y

-89.8%

HIK

UK£18.50

Hikma Pharmaceuticals

7D

1.8%

1Y

-5.2%

DPH

UK£38.66

Dechra Pharmaceuticals

7D

0.2%

1Y

32.4%